statistiche ricercatore

Continente	#
NA - Nord America	1.120
EU - Europa	995
AS - Asia	497
SA - Sud America	72
AF - Africa	26
Continente sconosciuto - Info sul continente non disponibili	3
OC - Oceania	2
Totale	2.715

Nazione	#
US - Stati Uniti d'America	1.100
GB - Regno Unito	259
RU - Federazione Russa	198
CN - Cina	196
IE - Irlanda	137
SG - Singapore	136
IT - Italia	88
UA - Ucraina	72
DE - Germania	70
SE - Svezia	65
BR - Brasile	57
FR - Francia	56
VN - Vietnam	46
HK - Hong Kong	38
KR - Corea	29
FI - Finlandia	26
ZA - Sudafrica	14
TR - Turchia	10
IN - India	9
CA - Canada	8
JP - Giappone	8
PL - Polonia	7
MX - Messico	6
AR - Argentina	5
BD - Bangladesh	5
ID - Indonesia	4
PK - Pakistan	4
BE - Belgio	3
CL - Cile	3
CM - Camerun	3
EC - Ecuador	3
IQ - Iraq	3
KE - Kenya	3
SK - Slovacchia (Repubblica Slovacca)	3
AM - Armenia	2
CO - Colombia	2
ES - Italia	2
HN - Honduras	2
NG - Nigeria	2
NL - Olanda	2
UZ - Uzbekistan	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
AU - Australia	1
BB - Barbados	1
BG - Bulgaria	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
CW - ???statistics.table.value.countryCode.CW???	1
CZ - Repubblica Ceca	1
DZ - Algeria	1
EG - Egitto	1
GR - Grecia	1
IM - Isola di Man	1
JM - Giamaica	1
JO - Giordania	1
KZ - Kazakistan	1
LT - Lituania	1
MA - Marocco	1
MY - Malesia	1
NZ - Nuova Zelanda	1
PT - Portogallo	1
SA - Arabia Saudita	1
SR - Suriname	1
SV - El Salvador	1
VE - Venezuela	1
Totale	2.713

Nome	#
Nuclear magnetic resonance for studying recognition processes between anandamide and cannabinoid receptors	311
Synthesis and in vitro pharmacological activity of oxypropanol analogs of labetalol	253
Design, Synthesis, and Binding Studies of New Potent Ligands of Cannabinoids Receptors	248
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium	242
New Resorcinol-Anandamide "Hybrids" as Potent Cannabinoid Receptor Ligands Endowed with antinociceptive activity in vivo	238
Nuovi Potenti e Selettivi ligandi dei recettori dei cannabinoidi	223
Design, synthesis, binding, and molecular modeling studies of new potent ligands of cannabinoid receptors	219
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol (2-AG) Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 (CB1) Receptor	218
Conformational Analysis of the N-Arachinylethanolamide (Anandamide) using Nuclear Magnetic Resonance and Theoretical Calculations	213
Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist	204
Identification and Quantification of Trans-Resveratrol in Dietary Supplements by a Rapid and Straightforward RP-HPLC Method	192
Synthesis, binding affinity and selectivity of new beta1 and beta2 adrenoceptor blockers	154
Totale	2.715

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	102	0	0	7	9	4	2	8	9	4	11	13	35
2022/2023	252	13	17	45	34	28	48	3	22	26	4	8	4
2023/2024	163	5	1	17	6	3	46	76	3	1	0	0	5
2024/2025	334	6	17	45	10	42	32	0	22	16	7	36	101
2025/2026	812	62	108	79	124	177	32	75	29	29	35	8	54
2026/2027	91	37	20	34	0	0	0	0	0	0	0	0	0
Totale													2.715